REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dci Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Dci Pharmaceuticals Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dci Pharmaceuticals Private Limited is a company based in India, with its head office in South Goa. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on December 29, 1975. In 2024, the company reported a net sales revenue increase of 33.49%. Over the same period, its total assets grew by 19.24%.

Legal Address
Anand Bhavan Old Station Road
South Goa; Goa; Postal Code: 403601

Contact Details: Purchase the Dci Pharmaceuticals Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Dci Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Dci Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
December 29, 1975
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Whole Time Director
Ownership Details
Purchase this report to view the information.
40%
Purchase this report to view the information.
30%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after Dci Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
33.49%▲
Total Operating Revenue
33.99%▲
Operating Profit
-22.54%▼
EBITDA
-13.04%▼
Net Profit/Loss for the Period
N/A
Total Assets
19.24%▲
Total Equity
-2.73%▼
Operating Profit Margin
-6.44%▼
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
-56.35%▼
Quick Ratio
-0.03%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo